DiaMedica Therapeutics Inc. (DMAC) Insider Trading -- Recent Executive & Director Transactions

11 insiders reported 44 Form 4 transactions for DiaMedica Therapeutics Inc. (DMAC) over the past 18 months (most recent 2026-08-12). Recent activity: Pauls Dietrich John (President & CEO) Buy 60,200 shares, Giuffre Randall Michael (Director) Buy 6,175 shares, Semba Charles Pauling (Director) Buy 3,355 shares, Parsons James T. (Director) Buy 10,095 shares, TRILL AB (Insider) Buy 208,872 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-08-12Pauls Dietrich JohnPresident & CEOBuy60,200$0
2026-01-06Giuffre Randall MichaelDirectorBuy6,175$51,994
2026-01-06Semba Charles PaulingDirectorBuy3,355$28,249
2026-01-06Parsons James T.DirectorBuy10,095$85,000
2025-12-08TRILL ABInsiderBuy208,872$1.5M
2025-12-08STAHLBERG JANInsiderBuy187,393$1.2M
2025-12-08TRILL ABInsiderBuy182,882$1.2M
2025-12-08STAHLBERG JANInsiderBuy182,882$1.2M
2025-12-08TRILL ABInsiderBuy240,352$1.7M
2025-12-08STAHLBERG JANInsiderBuy240,352$1.7M
2025-12-08TRILL ABInsiderBuy128,426$951,637
2025-12-08STAHLBERG JANInsiderBuy128,426$951,637
2025-12-08TRILL ABInsiderBuy187,393$1.2M
2025-12-08STAHLBERG JANInsiderBuy208,872$1.5M
2025-12-08TRILL ABInsiderBuy40,253$317,596
2025-12-08STAHLBERG JANInsiderBuy40,253$317,596
2025-12-08TRILL ABInsiderBuy73,099$626,458
2025-12-08STAHLBERG JANInsiderBuy73,099$626,458
2025-11-25Parsons James T.DirectorBuy12,000$26,400
2025-09-04STAHLBERG JANInsiderBuy293,601$1.7M
2025-09-04TRILL ABInsiderBuy293,601$1.7M
2025-09-04TRILL ABInsiderBuy70,414$421,780
2025-09-04STAHLBERG JANInsiderBuy70,414$421,780
2025-09-04TRILL ABInsiderBuy8,233$49,398
2025-09-04STAHLBERG JANInsiderBuy8,233$49,398

Source: SEC Form 4 filings · as of 2026-08-12